Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 928

Shanghai Cell Therapy diagnoses $39m series C1

Legend Capital has put its weight behind Shanghai Cell Therapy’s $39.6m series C1 round, two years after leading a $26.6m series B.

Nov 26, 2018

Topica Edtech studies $50m series D

CyberAgent-backed edtech company Topica has secured $50m in a series D round led by Northstar Group.

Nov 26, 2018

GLP helps deliver $216m to Juma Peisong

Juma Peisong has collected $216m in series C funding from investors including Global Logistic Properties to accelerate its expansion activities.

Nov 26, 2018

Kanova captures $16.6m series A

Legend-backed biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.

Nov 26, 2018

Elens articulates $21.6m

Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.

Nov 26, 2018

Kanova captures $16.6m series A

Biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.

Nov 26, 2018

Payfazz packs in $21m

Tiger Global and DST Global have invested $21m in the mobile wallet developer, which already counted Telkom Indonesia unit MDI Ventures as investors.

Nov 26, 2018

News round up 26 November 2018

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.

Nov 26, 2018

Happytal hatches $26m round

Axa has backed a $26..2m round for the patient gifting platform, which now plans to expand into Germany, the UK and Switzerland.

Nov 24, 2018

Corporate venturing deal net: 19-23 November 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Nov 23, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here